SC
BMY icon

Siena Capital’s Bristol-Myers Squibb BMY Stock Holding History

Siena Capital’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-250
Closed -$19K – 171
2022
Q2 		$19K Hold
250
– – 0.01% 119
2022
Q1 		$18K Sell
250
-42,056
-99% -$2.82M 0.01% 155
2021
Q4 		$2.64M Buy
+42,306
New +$2.48M 1.51% 18

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Siena Capital's BMY Position: Q3 2022 in Review

Siena Capital sold out of Bristol-Myers Squibb (BMY) in Q3 2022, closing a stake of 250 shares — an estimated $19K sold.

Siena Capital first reported a position in BMY in Q4 2021 and held it in 3 quarters. The position peaked at $2.64M in Q4 2021. 2,469 funds tracked by Wall St. Rank hold BMY as of Q3 2022.

  • Siena Capital reported no remaining Bristol-Myers Squibb position as of Q3 2022 after selling out during the quarter.
  • Siena Capital sold 250 Bristol-Myers Squibb shares in Q3 2022, an estimated $19K.
  • Siena Capital first reported a position in Bristol-Myers Squibb in Q4 2021 and held it in 3 quarters.
  • Siena Capital's Bristol-Myers Squibb position peaked at $2.64M in Q4 2021.
  • 2,469 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2022.

Based on Siena Capital's 13F filing for Q3 2022, filed 2 Nov 2022.